Cardinal Health, Inc. vs Henry Schein, Inc.
A head-to-head of Cardinal Health, Inc. (CAH) and Henry Schein, Inc. (HSIC) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | CAH | HSIC |
|---|---|---|
| Market Cap | $53.52B | $10.00B |
| P/E (TTM) | 34.94 | 25.44 |
| Forward P/E | 18.99 | 14.87 |
| P/S | 0.18 | 0.63 |
| P/B | -15.98 | 2.08 |
| EV/EBITDA | 12.49 | 12.80 |
| Dividend Yield | 0.91% | — |
| Profit Margin | 0.62% | 2.95% |
| Gross Margin | 3.67% | 31.14% |
| Operating Margin | 1.04% | 5.75% |
| Revenue Growth (YoY) | +11.05% | +6.31% |
| FCF Yield | 9.56% | 4.74% |
| Debt / Equity | — | 70.68 |
| Current Ratio | 0.91 | 1.36 |
Which is better: Cardinal Health, Inc. or Henry Schein, Inc.?
- ✓Larger by market cap: Cardinal Health, Inc.
- ✓Cheaper valuation (lower P/E): Henry Schein, Inc.
- ✓More profitable (net margin): Henry Schein, Inc.
- ✓Faster revenue growth: Cardinal Health, Inc.
- ✓Higher free-cash-flow yield: Cardinal Health, Inc.
Across 10 available metrics, Henry Schein, Inc. leads 6–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.